152 related articles for article (PubMed ID: 38022469)
1. Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody, in the Treatment of Severe Refractory Anti-N-methyl-D-Aspartate Receptor Encephalitis: Two Case Reports.
Xue H; Jiang Y; Qin L; Wang X; Zhang M; Dai S; Teng Y; Xu J; Li W
Ann Indian Acad Neurol; 2023; 26(5):774-777. PubMed ID: 38022469
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature.
Nan D; Zhang Y; Han J; Jin T
Neurol Sci; 2021 Mar; 42(3):847-855. PubMed ID: 33409829
[TBL] [Abstract][Full Text] [Related]
3. Co-occurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Anti-myelin Oligodendrocyte Glycoprotein Inflammatory Demyelinating Diseases: A Clinical Phenomenon to Be Taken Seriously.
Ren Y; Chen X; He Q; Wang R; Lu W
Front Neurol; 2019; 10():1271. PubMed ID: 31866928
[No Abstract] [Full Text] [Related]
4. The case report of MOG and NMDAR IgG double positive encephalitis treated with subcutaneous ofatumumab.
Zhang R; Wang L; Tao Y; Zhang X; Liu K; Song B; Xu Y
Front Immunol; 2023; 14():1183488. PubMed ID: 37649484
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment with immunoadsorption therapy in four patients with severe and refractory anti-N-methyl-D-aspartate receptor encephalitis.
Yang Y; Zhang B; Li M; Li J
J Clin Apher; 2021 Dec; 36(6):886-892. PubMed ID: 34520046
[TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy strategy for 35 cases of severe anti-N-methyl-D-aspartate receptor encephalitis].
Yuan J; Peng B; Guan HZ; Huang Y; Lu Q; Ren HT; Yang XZ; Jiang N; Zhu YC; Cui LY
Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(13):1035-9. PubMed ID: 27055797
[TBL] [Abstract][Full Text] [Related]
7. Brain astrocytoma misdiagnosed as anti-NMDAR encephalitis: a case report.
Lu J; Zhang JH; Miao AL; Yin JX; Zhu DL; Lin XJ; Chen DW; Shi JP
BMC Neurol; 2019 Aug; 19(1):210. PubMed ID: 31462223
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics of anti
Zheng J; Shen J; Wang A; Liu L; Xiong J; Li X; Xiao Y; Li J; Mao D; Liu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jan; 45(1):47-54. PubMed ID: 32132297
[TBL] [Abstract][Full Text] [Related]
9. A Case of Severe Anti-N-Methyl D-Aspartate (Anti-NMDA) Receptor Encephalitis with Refractory Autonomic Instability and Elevated Intracranial Pressure.
Salehi N; Yuan AK; Stevens G; Koshy R; Klein WF
Am J Case Rep; 2018 Oct; 19():1216-1221. PubMed ID: 30310049
[TBL] [Abstract][Full Text] [Related]
10. Surgical outcomes in patients with anti-N-methyl D-aspartate receptor encephalitis with ovarian teratoma.
Dai Y; Zhang J; Ren H; Zhou X; Chen J; Cui L; Lang J; Guan H; Sun D
Am J Obstet Gynecol; 2019 Nov; 221(5):485.e1-485.e10. PubMed ID: 31128109
[TBL] [Abstract][Full Text] [Related]
11. Risk Factors and Prognosis in Anti-NMDA Receptor Encephalitis Patients with Disturbance of Consciousness.
Gong Z; Lao D; Huang F; Lv S; Mao F; Huang W
Patient Relat Outcome Meas; 2023; 14():181-192. PubMed ID: 37337520
[TBL] [Abstract][Full Text] [Related]
12. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients.
Zhang Y; Liu G; Jiang M; Chen W; He Y; Su Y
Neurocrit Care; 2018 Oct; 29(2):264-272. PubMed ID: 29651625
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Wu Q; Xie Q; Liu L; Meng C; Wang J
Mult Scler Relat Disord; 2023 Jun; 74():104697. PubMed ID: 37031550
[TBL] [Abstract][Full Text] [Related]
14. Anti-N-methyl-d-aspartate receptor encephalitis in children: Incidence and experience in Hong Kong.
Ho AC; Chan SH; Chan E; Wong SS; Fung ST; Cherk SW; Fung EL; Ma KH; Tsui KW; Yau EK; Wong VC
Brain Dev; 2018 Jun; 40(6):473-479. PubMed ID: 29599011
[TBL] [Abstract][Full Text] [Related]
15. Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis.
Yan L; Zhang S; Huang X; Tang Y; Wu J
Front Neurol; 2021; 12():609750. PubMed ID: 33613429
[No Abstract] [Full Text] [Related]
16. The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity.
Yu Y; Wu Y; Cao X; Li J; Liao X; Wei J; Huang W
Mult Scler Relat Disord; 2021 Jan; 47():102604. PubMed ID: 33130468
[TBL] [Abstract][Full Text] [Related]
17. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
Tao S; Zhang Y; Ye H; Guo D
Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
[TBL] [Abstract][Full Text] [Related]
18. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes.
Wang Y; Zhang W; Yin J; Lu Q; Yin F; He F; Peng J
J Neuroimmunol; 2017 Nov; 312():59-65. PubMed ID: 28935354
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of prodromal headache in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Ma C; Wang C; Zhang Q; Lian Y
J Pain Res; 2019; 12():519-526. PubMed ID: 30787630
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of intra-thecal methotrexate in refractory Anti-N-methyl-d-aspartate receptor encephalitis.
Hommady R; Alsohibani A; Alayed R; Alshehri A; AbuMelha A; Aljomah L; Hundallah K; Almuqbil M; Altuwaijri W; Alrumayyan A; Alrifai MT; Baarmah DM
BMC Neurol; 2023 Jul; 23(1):261. PubMed ID: 37420168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
